Inventor · disambiguated record
Lawrence P. Wennogle
Also filed as: WENNOGLE LAWRENCE · WENNOGLE LAWRENCE P
99 granted patents·30 pending applications·2,967 citations·filing 2006–2025
99Inventor score
Top patents by PatentIndex Score
129 records- 0199US10702522B2Methods and compositions for sleep disorders and other disordersINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jul 7, 2020·40 cites·12 claims
- 0299US10117867B2Methods and compositions for sleep disorders and other disordersINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Nov 6, 2018·57 cites·28 claims
- 0399US9371324B2Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disordersINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jun 21, 2016·90 cites·26 claims
- 0499US9168258B2Methods and compositions for sleep disorders and other disordersINTRA CELLULAR THERAPIES INC·Filed 2013·Granted Oct 27, 2015·106 cites·20 claims
- 0598US12023331B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Jul 2, 2024·10 cites·26 claims
- 0698US11958852B2Compounds and methodsINTRA CELLULAR THERAPIES INC·Filed 2021·Granted Apr 16, 2024·11 cites·16 claims
- 0798US11680065B2Pharmaceutical compositions comprising 4-(6Br,10aS)-3-methyl-2, 3, 6b, 9, 10, 10a-hexahydro-1H, 7H-pyrido[3′, 4′, 5] pyrolo[1,2,3-de] quinoxalin-8YL)-1-(4-fluorophenyl)-butane-1-one and methods of treating conditions of the central nervous systemINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Jun 20, 2023·17 cites·19 claims
- 0898US11560382B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Jan 24, 2023·17 cites·25 claims
- 0998US11124514B2Compositions and methodsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Sep 21, 2021·40 cites·14 claims
- 1098US11026951B2Methods of treating bipolar disorderINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jun 8, 2021·38 cites·24 claims
- 1198US10960010B2Pharmaceutical compositions for sustained or delayed releaseINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 30, 2021·38 cites·24 claims
- 1298US10960009B2Methods of treating schizophrenia and depressionINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 30, 2021·39 cites·19 claims
- 1398US10899762B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Jan 26, 2021·29 cites·21 claims
- 1498US10844061B2Pharmaceutical compositions comprising 4-(6BR,10AS)-3-methyl-2,3,6B,9,10,10A-hexahydro-1h, 7H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)butan-1-one and methods of treating conditions of the central nervous systemINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 24, 2020·33 cites·17 claims
- 1598US10597394B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Mar 24, 2020·30 cites·13 claims
- 1698US10472359B2Pharmaceutical compositions comprising 4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl) butan-1-one for inhibiting serotonin reuptake transporter activityINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Nov 12, 2019·35 cites·20 claims
- 1798US10464938B2Pharmaceutical compositions comprising ((6bR,10aS)-1-(4-fluorophenyl)-4-(3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one or pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 5, 2019·33 cites·12 claims
- 1898US10322134B2MethodsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Jun 18, 2019·49 cites·20 claims
- 1998US10077267B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Sep 18, 2018·69 cites·18 claims
- 2098US10072010B2Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activityINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Sep 11, 2018·53 cites·16 claims
- 2198US9956227B2Method for the treatment of residual symptoms of schizophreniaINTRA CELLULAR THERAPIES INC·Filed 2014·Granted May 1, 2018·78 cites·25 claims
- 2298US9751883B2Preparation of certain [((6BR,10AS)-2,3,6B,7,8,9,10, 10A-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2016·Granted Sep 5, 2017·86 cites·28 claims
- 2398US9745300B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Aug 29, 2017·82 cites·40 claims
- 2498US9708322B2Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activityINTRA CELLULAR THERAPIES INC·Filed 2014·Granted Jul 18, 2017·93 cites·7 claims
- 2598US9616061B2Methods and compositions for sleep disorders and other disordersINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Apr 11, 2017·93 cites·29 claims
- 2698US9586960B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de] quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal formsTOMESCH JOHN·Filed 2015·Granted Mar 7, 2017·90 cites·2 claims
- 2798US9428506B2Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disordersINTRA CELLULAR THERAPIES INC·Filed 2013·Granted Aug 30, 2016·82 cites·30 claims
- 2898US9315504B2Preparation of 4-((6BR,10AS)-3-methyl-2,3,6B,9,10, 10A-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo [1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone or a pharmaceutically acceptable salt thereofINTRA CELLULAR THERAPIES INC·Filed 2014·Granted Apr 19, 2016·88 cites·5 claims
- 2998US9199995B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystalsTOMESCH JOHN·Filed 2014·Granted Dec 1, 2015·94 cites·14 claims
- 3098US8664207B2Organic compoundsLI PENG·Filed 2009·Granted Mar 4, 2014·99 cites·31 claims
- 3198US8648077B24-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid addition salt and salt crystalsTOMESCH JOHN·Filed 2009·Granted Feb 11, 2014·133 cites·27 claims
- 3298US8598119B2Methods and compositions for sleep disorders and other disordersMATES SHARON·Filed 2009·Granted Dec 3, 2013·138 cites·29 claims
- 3397US11980617B2Methods of treating acute depression and/or acute anxietyINTRA CELLULAR THERAPIES INC·Filed 2019·Granted May 14, 2024·17 cites·35 claims
- 3497US11759465B2UsesINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Sep 19, 2023·8 cites·18 claims
- 3597US11504372B2UsesINTRA CELLULAR THERAPIES INC·Filed 2020·Granted Nov 22, 2022·4 cites·4 claims
- 3697USRE48839EMethods and compositions for sleep disorders and other disordersINTRA CELLULAR THERAPIES INC·Filed 2009·Granted Dec 7, 2021·21 cites·37 claims
- 3797USRE48825E4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone toluenesulfonic acid salt crystal formsINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Nov 23, 2021·13 cites·23 claims
- 3897US11066407B2Preparation of certain substituted 1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Jul 20, 2021·14 cites·10 claims
- 3997US10682354B2Compositions and methodsINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Jun 16, 2020·15 cites·26 claims
- 4097US10597395B2Preparation of certain substituted 1-(4-fluorophenyl)-4-(2,3,6b,9,10,10a-hexahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-YL)butan-1-ones and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2019·Granted Mar 24, 2020·23 cites·19 claims
- 4197US10221176B2Preparation of certain substituted [((6bR,10aS)-2,3,6b,7,8,9,10,10a-octahydro-1H-pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines and pharmaceutically acceptable salts thereofINTRA CELLULAR THERAPIES INC·Filed 2017·Granted Mar 5, 2019·28 cites·29 claims
- 4297US9073936B2Organic compoundsLI PENG·Filed 2014·Granted Jul 7, 2015·38 cites·22 claims
- 4397US8993572B2Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivativesMATES SHARON·Filed 2011·Granted Mar 31, 2015·112 cites·19 claims
- 4497US8779139B2Substituted 2,3,4,4A,5,9B-hexahydro-1H-pyrido[4,3-B]indole derivatives synthesis and uses thereofTOMESCH JOHN CHARLES·Filed 2012·Granted Jul 15, 2014·108 cites·15 claims
- 4597US8697710B2Optionally substituted 3-amino-4-(thioxo or imino)-4,5-dihydro-2H-pyrazolo [3,4-d]pyrimidin-6(7H)-onesLI PENG·Filed 2009·Granted Apr 15, 2014·96 cites·29 claims
- 4697US8633180B2Organic compoundsLI PENG·Filed 2009·Granted Jan 21, 2014·97 cites·32 claims
- 4797US8536159B2Organic compoundsLI PENG·Filed 2009·Granted Sep 17, 2013·98 cites·30 claims
- 4896US11440911B2Salts and crystalsINTRA CELLULAR THERAPIES INC·Filed 2018·Granted Sep 13, 2022·11 cites·5 claims
- 4994US9556186B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jan 31, 2017·14 cites·27 claims
- 5094US9546175B2Organic compoundsINTRA CELLULAR THERAPIES INC·Filed 2015·Granted Jan 17, 2017·8 cites·16 claims
Showing the top 50 of 129 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Lawrence P. Wennogle files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →